Exploring the Use of Oral Pre-exposure Prophylaxis (PrEP) Among Women from Durban, South Africa as Part of the HIV Prevention Package in a Clinical Trial.
Exploring the Use of Oral Pre-exposure Prophylaxis (PrEP) Among Women from Durban, South Africa as Part of the HIV Prevention Package in a Clinical Trial.
复制标题
DOI:
10.1007/s10461-020-03072-0
复制
发表时间:
2021-04
影响因子:
4.4
通讯作者:
Mansoor LE
中科院分区:
文献类型:
--
作者:
Beesham I;Heffron R;Evans S;Baeten JM;Smit J;Beksinska M;Mansoor LE
HIV endpoint-driven clinical trials in Africa enroll women who are at heightened risk of acquiring HIV. In 2017, the South African Medical Research Council recommended the provision of oral pre-exposure prophylaxis (PrEP) in HIV prevention trials, at which time the Evidence for Contraceptive Options and HIV Outcomes trial was ongoing and began to provide PrEP on-site at some trial sites. We interviewed 132 women who initiated PrEP on-site at the Durban, South Africa trial site to explore PrEP use, and conducted phone-based interviews 4–6 months post-trial exit to explore post-trial PrEP access. PrEP uptake was high (42.6%). Among women initiating PrEP on-site, 87.9% felt at risk of acquiring HIV. Most women (> 90%) heard of PrEP for the first time from study staff and three-quarters who initiated PrEP on-site continued at trial-exit. PrEP use declined post-trial exit with more than 50% of women discontinuing PrEP, and barriers relating to access emerged.
登录
查看更多内容
影响因子:
16.1
作者:
Janes, Holly;Donnell, Deborah;Nason, Martha
通讯作者:
Nason, Martha
影响因子:
6
作者:
Velloza, Jennifer;Khoza, Nomhle;Delany-Moretlwe, Sinead
通讯作者:
Delany-Moretlwe, Sinead
影响因子:
168.9
作者:
Baeten, Jared M.;Donnell, Deborah;Stringer, Jeffrey
通讯作者:
Stringer, Jeffrey
影响因子:
6
作者:
Beesham, Ivana;Welch, Julia D.;Baeten, Jared M.
通讯作者:
Baeten, Jared M.
影响因子:
6
作者:
Celum, Connie L.;Delany-Moretlwe, Sinead;Bekker, Linda-Gail
通讯作者:
Bekker, Linda-Gail